| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 36405-47-7 | 甲基丙烯酸六氟丁酯 | 2,2,3,4,4,4-Hexafluorobutyl methacrylate; 1,1,3-Trihydroperfluorobutylmethacrylate; 2,2,3,4,4,4-Hexafluorobutyl methacrylate; Light Ester M 6F; a,a,g-Trihydroperfluorobutyl methacrylate |  | C8H8F6O2 | 詳情 | 供應(yīng)商 |
| 2041-56-7 | Cyclobutanemethanol,1-(aminomethyl)-; 1-Hydroxymethyl-1-cyclobutylmethylamine |  | C6H13NO | 詳情 | 供應(yīng)商 | |
| 101516-99-8 | Glycine,N-[[[(4-hydroxy-3-methoxyphenyl)methyl]amino]thioxomethyl]-, butyl ester; 1-CARBObutylmetHYL-3-VANILLYL-2-THIOUREA |  | C15H22N2O4S | 詳情 | 供應(yīng)商 | |
| 894101-37-2 | Hydrazine,(cyclobutylmethyl)-; 1-(cyclobutylmethyl)hydrazine |  | C5H12N2 | 詳情 | 供應(yīng)商 | |
| 42408-82-2 | 布托啡諾 | Morphinan-3,14-diol,17-(cyclobutylmethyl)-; (-)-17-(Cyclobutylmethyl)-3,14b-dihydroxymorphinan; (-)-Butorphanol; BC 2627, (-)-; Butorphanol; Levo-BC 2627; l-3,14-Dihydroxy-N-(cyclobutylmethyl)morphinan; l-BC 2627 |  | C21H30NO2 | 詳情 | 供應(yīng)商 |
| 23277-43-2 | Morphinan-3,6,14-triol,17-(cyclobutylmethyl)-4,5-epoxy-, hydrochloride (1:1), (5a,6a)-; Morphinan-3,6,14-triol,17-(cyclobutylmethyl)-4,5-epoxy-, hydrochloride, (5a,6a)- (9CI); Morphinan-3,6a,14-triol, 17-(cyclobutylmethyl)-4,5a-epoxy-, hydrochloride (8CI); 17-(Cyclobutylmethyl)-4,5a-epoxymorphinan-3,6a,14-triol hydrochloride; EN 2234A; MCV 4385; N-Cyclobutylmethyl-7,8-dihydro-14-hydroxynormorphine hydrochloride; NIH 10274; Nalbuphine hydrochloride; Nalufin; Nubain; UM 686 |  | C21H29ClNO4 | 詳情 | 供應(yīng)商 | |
| 77287-89-9 | Morphinan-3-ol,17-(cyclobutylmethyl)-8-methyl-6-methylene-, (8b)-; 17-(Cyclobutylmethyl)-8b-methyl-6-methylenemorphinan-3-ol; 17-Cyclobutylmethyl-3-hydroxy-8b-methyl-6-methylenemorphinane; TR 5379; Xorphanol |  | C23H31NO | 詳情 | 供應(yīng)商 | |
| 64643-71-6 | Morphinan-6-one,17-(cyclobutylmethyl)-4,5-epoxy-14-hydroxy-3-methoxy-, (5a)- (9CI); (5alpha)-17-(cyclobutylmethyl)-4,5-epoxy-14-hydroxy-3-methoxymorphinan-6-one |  | C22H28NO4 | 詳情 | 供應(yīng)商 | |
| 82534-54-1 | Piperazine,1-(cyclobutylmethyl)-; 1-(Cyclobutylmethyl)piperazine |  | C9H18N2 | 詳情 | 供應(yīng)商 | |
| 19435-65-5 | N-BSMOC-N-乙基乙烷-1,2-二胺 | 1,2-Ethanediamine,N1-butyl-N1-methyl-; 1,2-Ethanediamine,N-butyl-N-methyl- (9CI); Ethylenediamine, N-butyl-N-methyl- (8CI); 2-(butylmethylamine)ethylamine |  | C7H18N2 | 詳情 | 供應(yīng)商 |
| 35501-27-0 | 1-Propanamine,3-(dibutylmethylsilyl)-; Dibutyl(methyl)(3-aminopropyl)silane; Methyldibutyl-(3-aminopropyl)silane; Propylamine, 3-(dibutylmethylsilyl)- |  | C12H29NSi | 詳情 | 供應(yīng)商 | |
| 52371-85-4 | 1-Butanamine,N-butyl-N-[3-(dibutylmethylsilyl)propyl]- |  | C20H45NSi | 詳情 | 供應(yīng)商 | |
| 172595-53-8 | 1H-Indole-3-acetamide,N-[8-(butylmethylamino)-8-oxooctyl]-1-(4-chlorobenzoyl)-5-hydroxy-2-methyl-; MDL 101906 |  | C31H40ClN3O4 | 詳情 | 供應(yīng)商 | |
| 885266-92-2 | 1H-1,4-Diazepine-1-carboxylicacid, 4-(cyclobutylmethyl)hexahydro-, 1,1-dimethylethyl ester |  | C15H28N2O2 | 詳情 | 供應(yīng)商 | |
| 775522-48-0 | 1,2-Benzenediol,4-[2-(butylmethylamino)ethyl]-; 1,2-Benzenediol, 4-[2-(butylmethylamino)ethyl]- (9CI) |  | C13H21NO2 | 詳情 | 供應(yīng)商 | |
| 1155-65-3 | 1,4-Cyclohexanebis(methylamine),N,N'-bis(cyclobutylmethyl)-, dihydrochloride, trans- (8CI) |  | C18H36Cl2N2 | 詳情 | 供應(yīng)商 | |
| 801987-97-3 | 1H-Pyrazolo[3,4-d]pyrimidin-4-amine,N-butyl-N,1-dimethyl-; 1H-Pyrazolo[3,4-d]pyrimidine,4-(butylmethylamino)-1-methyl- (8CI) |  | C11H17N5 | 詳情 | 供應(yīng)商 | |
| 64037-63-4 | 1,2-Benzenediol,4-[2-(butylmethylamino)-1-hydroxyethyl]-, (R)- (9CI) |  | C13H21NO3 | 詳情 | 供應(yīng)商 | |
| 705945-70-6 | (R)-TCFP-RH; (R)-(-)-T-butylmetHYL(DI-T-BUTYLPHOSPHINOMETHYL)PHOSPHINO(1,5-CYCLOOCTADIENE)RHODIUM(I) TETRAFLUOROBORATE; (R)-TCFP-RH |  | C22H44BF4P2Rh-2 | 詳情 | 供應(yīng)商 | |
| 705945-68-2 | (S)-TCFP-RH; (S)-(+)-T-butylmetHYL(DI-T-BUTYLPHOSPHINOMETHYL)PHOSPHINO(1,5-CYCLOOCTADIENE)RHODIUM(I) TETRAFLUOROBORATE; (S)-TCFP-RH |  | C22H44BF4P2Rh-2 | 詳情 | 供應(yīng)商 | |